AzTrials
AzTrials

Kidney TransplantationDOVIREINNCT02830568

Medical Economic Evaluation and of Quality of Life of the Kidney Living Donors.

An observational study of Kidney Transplantation, run by Central Hospital, Nancy, France at 24 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The main objective of this multicentre study is to conduct the evaluation of cost-efficiency of various techniques of kidney taking with regard the quality of life of the kidney living donors. Read more about this study

Who is it for?
Any age
Conditions the study is for
Kidney Transplantation
What is being tested?
open donor nephrectomy, standard and hand-assisted laparoscopic donor nephrectomy and laparoscopic robotic-assisted nephrectomy
Type of treatment
Surgery or procedure
How many people
268 participants
Where
24 sitesFrance
Study dates
Jun 2010to Jul 2013
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Couples living donor - receiver of the services of urology and nephrology of 24 CHU in France practicing one of three techniques : * Classic surgical taking by lombotomie : Besançon, Bicêtre, Caen, Lille, Marseille, Strasbourg, Tenon; * Taking by coeliosurgery pure or hand-assisted : Clermont-Ferrand, Créteil, Foch, Grenoble, La Pitié Salpêtrière, Lyon Sud, Montpellier, Nantes, Necker,Saint-Etienne,Saint-Louis,Toulouse, Rouen; * Coeliosurgical taking assisted by robot : Nancy, Nice, Lyon, Tours.

Who may be able to join

  • The receiver is registered on the ABM list;
  • The receiver is on dialysis or in preterminal renal insufficiency;
  • The donor is a member of the circle of acquaintances of the receiver.

Who cannot join

  • Risk of difficulties of follow-up during 3 months following the transplant (ex: patient not living in France);
  • Refusal of participation of the donor.

Trial locations and contacts

24 sites in 1 country.

24 sites in 1 country

France24 sites
  • CHU Saint Jacques de Besançon

    Besançon, 25030

  • CHU Côte de Nacre de CAEN

    Caen, 14000

  • CHU Montpied de Clermont-Ferrand

    Clermont-Ferrand, 63003

  • CHU Henri Mondor

    Créteil, 94010

  • CHU Hôpital Michallon de Grenoble

    Grenoble, 38043

  • CHU Bicêtre

    Le Kremlin-Bicêtre, 94275

  • Hôpital Claude Huriez

    Lille, 59000

  • CHU Lyon Sud

    Lyon, 69000

  • Hôpital Edouard Herriot de Lyon

    Lyon, 69437

  • CHU Hôpital de la Conception

    Marseille, 13274

  • CHU Lapeyronie

    Montpellier, 34295

  • CHU Brabois

    Nancy, 54000

  • CHU Hôtel Dieu

    Nantes, 44093

  • CHU Pasteur

    Nice, 06002

  • Hôpital Necker

    Paris, 75015

  • Hôpital Pitié Salpêtrière

    Paris, 75651

  • Hôpital Saint-Louis

    Paris, 75970

  • Hôpital Tenon

    Paris, 75970

  • Hôpital Charles Nicolle

    Rouen, 76038

  • CHU Saint Etienne

    Saint-Etienne, 42000

  • CHU Hautepierre

    Strasbourg, 67091

  • CMC Foch

    Suresnes, 92151

  • Hôpital de Rangueil

    Toulouse, 31059

  • CHU Bretonneau

    Tours, 37000

Other trials in France

About this study

Official title: Medical Economic Evaluation and of Quality of Life of the Kidney Living Donors. Comparison of the Taking of Kidney by cœliosurgery (Pure or " Hand-assisted "), by cœliosurgery Assisted by Robot and by the Classic Technique of Open Donor Nephrectomy.

The main objective of this multicentre study is to conduct the evaluation of cost-efficiency of various techniques of kidney taking with regard the quality of life of the kidney living donors.

It will allow to compare three techniques of taking (open donor nephrectomy, cœliosurgery pure or " hand-assisted " and cœliosurgery assisted by robot) and to determine their respective advantages in quality of life, then their medico-economic consequences in a cost-efficiency approach from the point of view of the society.

Read more

The evaluation will concern the donor and the receiver followed three months after the taking.

The open donor nephrectomy will be the technique of reference with which will be compared the two others.

Read the detailed description

Context : The most efficient treatment of the terminal chronic renal insufficiency is the renal transplantation, but in spite of the realization of more than 2000 transplants a year in France, the waiting list increases every year in a important way. The decrease of the offer of transplants from deathly donors led numerous countries to develop the renal transplant from alive donors. This type of transplantation represents in 2007 only 8,1 % of transplants in France (report of ABM on 2007), but the deficit in renal transplants and the new laws of bioethics should increase this donation (it represents until 70 % of the renal transplantations in certain centres of North America or the Northern Europe).

Although the French urology is at the top of the laparoscopic technique, the classic surgical taking by lombotomie stays the reference technique, practised by 58 % of the centres, with for the patient its consequences in terms of pain, of duration of hospitalization, convalescence and possible side effects. The development of the taking by cœliosurgery, mini-invasive technique, allowed to increase the number of wishes of organ donation in the centres which developed it. It is however a difficult technical gesture, requiring an important experience. This technique has the inconvenience of a more painful scar and more subject to complications than the section known pubic of "Pfannenstiel" used for the taking by pure cœliosurgery.

The surgical robot Da Vinci (Intuitive Surgical, Sunnyvale, California), with a 3D mink, the joints of the instruments inside the body, the reduction of the movements, the best ergonomics, improves the precision of the cœlioscopic gesture, but has a sharply upper cost. The CHU of Nancy was the pioneer in Europe to develop this technique from 2002, with very encouraging results on a series from now on more than 80 patients.

Only retrospective studies compared the quality of life between these techniques, and in spite of the major financial impacts (10 years of dialysis represent 100 K€; the price of the robot is of 1700 K€) and the important differences of quality of life according to these various surgical approaches, no prospective comparative medico-economic study was realized up to now. In France, where the hospital bears the load of all the expenses concerning the donor, including its daily allowances during its medical certificate, the shortening of the hospitalization and of the convalescence of the donor as well as the results improved by the transplantation at the receiver of a kidney living donor would allow a fast amortization of these expensive technologies.

Main objective : To compare the cost and the efficiency of the three techniques of taking of kidney living donor.

Main assessment criterion : The quality of life of the donor tested by generic measuring instruments EUROQOL and SF-36 (both to D-1 (the day before the renal transplantation), D4 (4 days after) and D90 (3 months after) and SF-36 to D-1 and D90). It will be realized at the donor's in preoperative (D-1), in postoperative (D4) and in the visit of follow-up in 3 months (D90). It will be also collected at the receiver's in preoperative (D-1), postoperative immediate (D4) and in the visit of follow-up in 3 months (D90).

The combination with the cost estimate will allow to build the marginal cost-efficiency ratio.

Secondary objectives envisaged:

  • The evaluation of the quality of life of the receiver by measuring instrument becomes generic EUROQOL and SF-36 to D-1, D4 (only Euroqol) and D90.
  • The comparison of the comfort of the surgeon and his physical and psychic investment by index card(form) of specific evaluation (Borg and NASA-TLX).
  • The comparison of the coelio-surgical techniques : pure coelioscopy, coelioscopy " hand-assisted " and coelioscopy assisted by robot will concern the quality of life and the marginal cost-efficiency ratio.
Being tested
open donor nephrectomy, standard and hand-assisted laparoscopic donor nephrectomy, laparoscopic robotic-assisted nephrectomy
Keywords
Kidney transplantation, Surgical procedures, Kidney living donors, Quality of life

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • open donor nephrectomyProcedure or surgery

    open donor nephrectomy

  • standard and hand-assisted laparoscopic donor nephrectomyProcedure or surgery

    standard and hand-assisted laparoscopic donor nephrectomy

  • laparoscopic robotic-assisted nephrectomyProcedure or surgery

    laparoscopic robotic-assisted nephrectomy

Study groups in NCT02830568
Study groupRoleWhat they receive
couples kidney living donor - receiverThree groups for each technique of taking of kidney : 1. open donor nephrectomy 2. standard and hand-assisted laparoscopic donor nephrectomy 3. laparoscopic robotic-assisted nephrectomy
Receives: Procedure: open donor nephrectomy; Procedure: standard and hand-assisted laparoscopic donor nephrectomy; Procedure: laparoscopic robotic-assisted nephrectomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Quality of life of the donor

    Quality of life of the donor as measured by EUROQOL (score 0 to 1) and SF 36 self-administered questionnaires (score 0 to 100 in each of 8 dimensions , at D-1 (the day before nephrectomy), D4 (4 days after nephrectomy) and D90 (90 days after nephrectomy).

    biological values of the donor and the receiver

    Measured: D-1 (day before nephrectomy), D4 (4 days after nephrectomy) and D90 (90 days after nephrectomy)

Secondary outcomes (6)
  1. Sociodemographic data

    At D-1 (the day before nephrectomy), sociodemographic data are collected

    Measured: D-1, the day before nephrectomy

  2. Comfort, physical and mental investment of the surgeon measured by the Borg and the NASA-TLX scale

    The Borg scale consists of 7 questions corresponding to the level of discomfort in 7 body segments of the surgeon with responses ranging from 0 (no discomfort) to 10 (very very strong discomfort). The surgeon is questioned every 30 minutes during the surgery. The NASA-TLX scale consists in 8 questions about physical and mental investment with responses ranging from 0 (low) to 100 (high). The surgeon completes this scale immediately at the end of the surgical procedure.

    Measured: Day 0, the actual day of nephrectomy for each donor

  3. Biological values of the donor and the receiver

    Blood count and serum electrolyte levels are collected. biological values of the donor and the receiver

    Measured: D-1 (day before nephrectomy), D2 (2 days after nephrectomy) D4 (4 days after nephrectomy) and D90 (90 days after nephrectomy)

  4. Treatments administered to the donor

    Treatments administered to the donor from D0 (the actual day of nephrectomy for each donor) to D90 (90 days after nephrectomy).

    Measured: D0 (the actual day of nephrectomy for each donor), D2 (2 days after nephrectomy), D4 (4 days after nephrectomy) and D90 (90 days after nephrectomy)

  5. Medical exams performed on the donor

    Medical exams performed on the donor from D0 (the actual day of nephrectomy for each donor) to D90 (90 days after nephrectomy).

    Measured: D-1 (day before nephrectomy), D2 (2 days after nephrectomy) D4 (4 days after nephrectomy) and D90 (90 days after nephrectomy)

  6. Information on surgical technique employed to achieve nephrectomy and description of the graft.

    Type of surgery (open donor nephrectomy, standard or hand-assisted laparoscopic donor nephrectomyor laparoscopic robotic-assisted nephrectomy), Duration of surgery and of ischemia and description of the graft.

    Measured: Day 0, the actual day of nephrectomy for each donor

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jul 2016 (estimated)
  2. Study startJun 2010
  3. Primary completionJul 2013
  4. Study completionJul 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
268 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02830568
Sponsor's protocol ID
10.039
Acronym
DOVIREIN
Status last verified
May 2010
First submitted
7 Jun 2010
Last updated
13 Jul 2016
Results posted
No
Data monitoring committee
Yes

Publications

  • Achit H, Guillemin F, Karam G, Ladriere M, Baumann C, Frimat L, Hosseini K, Hubert J. Cost-effectiveness of four living-donor nephrectomy techniques from a hospital perspective. Nephrol Dial Transplant. 2020 Nov 1;35(11):2004-2012. doi: 10.1093/ndt/gfz143.

    PubMed 31377771

Questions about this trial

What is this clinical trial studying?

An observational study of Kidney Transplantation, run by Central Hospital, Nancy, France at 24 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Jul 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 24 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Quality of life of the donor (time frame: D-1 (day before nephrectomy), D4 (4 days after nephrectomy) and D90 (90 days after nephrectomy)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02830568, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jul 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in